Concepedia

Ceilidh C. McConnachie

CC

4

Publications

113

Citations

4

H-Index

2017

Active since

Affiliations

Boehringer Ingelheim (France)(Current)

Ceilidh C. McConnachie is an author at Boehringer Ingelheim (France) specializing in medicine, pharmacotherapy, and diabetes.

Top concepts

MedicineDiabetesPathologyImmunologyInflammationMicrobiologyPathogenesisPharmacologyPharmacotherapyFood Microbiology

Publications per year

2017–2020

4

Publications

4

Propionic Acid Promotes the Virulent Phenotype of Crohn’s Disease-Associated Adherent-Invasive Escherichia coli

Michael J. Ormsby, Síle A. Johnson, Núria Carpena et al. · Cell Reports · 2020 · 63 citations · Full text

Dysbiosis, Immunology, Pathology +18

Long-term Cost-effectiveness of Two GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus in the Italian Setting: Liraglutide Versus Lixisenatide

Barnaby Hunt, Nana Kragh, Ceilidh C. McConnachie et al. · Clinical Therapeutics · 2017 · 24 citations

Diabetes Management, Diabetes, Pharmacology +5

Evaluating the short-term cost-effectiveness of liraglutide versus lixisenatide in patients with type 2 diabetes in the United States

Barnaby Hunt, Ceilidh C. McConnachie, Cory Gamble et al. · Journal of Medical Economics · 2017 · 13 citations

Evaluating the cost-effectiveness of afatinib after platinum-based therapy for the treatment of squamous non-small-cell lung cancer in France

M. Pignata, C. Chouaïd, K Le Lay et al. · ClinicoEconomics and Outcomes Research · 2017 · 13 citations · Full text

Rows per page

1–4 of 4